September 1-2, 2026
Marina Bay Sands, Sands Expo & Convention CentreSingapore Bo YingCEO at Abogen BiosciencesSpeaker
Profile
Dr. Bo Ying is the founder and CEO of Abogen Biosciences, the leading mRNA company in China focused on developing innovative mRNA technologies for prophylactic vaccines, cancer and autoimmune diseases. He has many years of experiences in the development of nucleic acid-based therapeutics and has held various roles in leading biopharmaceutical companies in Boston. His work has been published in journals such as Cell, Lancet Microbe, and he is also the inventor of 100+ patents and patent applications. Dr. Ying has a bachelor’s degree from Fudan University in China and a Ph.D. degree from Northeastern University in Boston.
Agenda Sessions
Presentation: Unlocking Recent Clinical Progress of mRNA-Based Cancer Vaccines & B-Cell Depletion Therapies
, 11:30amView Session